Cormorant Asset Management LP

Cormorant Asset Management LP

Cormorant Asset Management LP

Date Founded



200 Clarendon Street,52nd floor,Boston, MA 02116-5095

Type of Company


Employees (Worldwide)

1 - 10


Hedge Funds
Accounting & Financial Services
Investment Services & Portfolio Management

Company Description

Cormorant Asset Management’s Hedge Fund seeks superior risk-adjusted returns with low market correlation through a combination of long investment positions and short selling to achieve capital appreciation while attempting to preserve capital and mitigate risk by hedging activities. Most of the Hedge Funds’ assets are invested on a global basis in publicly traded equity securities in the healthcare and life science industries. The Private Equity Funds aims to generate significant long-term capital appreciation by creating or investing in market innovative companies in the biotechnology and life sciences marketplace. Cormorant intends to achieve this objective by primarily investing in privately held early state, later stage developmental and “crossover” (or mezzanine) round or pre-IPO biotech and life sciences companies. The firm uses a fundamental, research intensive approach that focuses primarily on scientific research to identify investment opportunities.

Contact Data
Trying to get in touch with decision makers at Cormorant Asset Management LP? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Founder, Chief Executive Officer & Portfolio Manager

Member, Chief Compliance Officer, Chief Financial Officer & Chief Operating Officer

Paths to Cormorant Asset Management LP
Potential Connections via
Relationship Science
Cormorant Asset Management LP
Advisors & Consultants

Morgan Stanley & Co. LLC is a registered broker-dealer subsidiary of Morgan Stanley Domestic Holdings, Inc., ultimately owned by Morgan Stanley (NYSE: MS). The firm was founded in 1987 and is headquartered in New York City. Morgan Stanley & Co. provides debt and equity services including underwriting, M&A advice, securities dealing and brokerage and trade execution. Their client base ranges from large global institutional investors to hedge funds at the cutting edge of innovation in the industry.


Deloitte & Touche LLP engages in the provision of audit, advisory, financial advisory, tax, and consulting services. The company was founded on March 7, 1995 and is headquartered in New York, NY.

Details Hidden

Otonomy, Inc. operates as a biopharmaceutical company. It engages in the development of therapeutics for neurotology. The firm’s product pipeline includes OTIVIDEX (dexamethasone) Meniere's disease, OTIPRIO (ciprofloxacin otic suspension) acute otitis media with tubes (AOMT), OTO-313 (gacyclidine) tinnitus, OTO-413 (BDNF) hidden hearing Loss, OTO-510 (otoprotectant) prevent CIHL, OTO-6XX (hair cell regeneration) severe hearing loss. It operates under the Otiprio brand. The company was founded by Jay B. Lichter, Jeffrey Harris, Rick Friedman, and Allen F. Ryan on May 6, 2008 and is headquartered in San Diego, CA.

Details Hidden

Zylox-Tonbridge Medical Technology Co., Ltd. operates as a medical devices company. The company was founded by Dr. Zhong Zhao on November 6, 2012 and is headquartered in Hangzhou, China.

Details Hidden

Aclaris Therapeutics, Inc. operates as a dermatologist-led biopharmaceutical company, which engages in identifying, developing, and commercializing novel drugs to address the needs in medical and aesthetic dermatology and immunology. It operates through Therapeutics and Contract Research segments. The Therapeutics segment focuses in identifying, developing, and commercializing different therapies to address significant unmet needs in medical and aesthetic dermatology. The Contract Research segment provides laboratory services under contract research arrangements to pharmaceutical and biotech companies. The company was founded by Neal S. Walker, Frank Ruffo, Kamil Ali-Jackson, Christopher V. Powala, and Stuart D. Shanler in July 2012 and is headquartered in Wayne, PA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Cormorant Asset Management LP. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Cormorant Asset Management LP's profile does not indicate a business or promotional relationship of any kind between RelSci and Cormorant Asset Management LP.